Compare RNA & CMTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNA | CMTV |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | 139 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.5M | 236.7M |
| IPO Year | 2025 | N/A |
| Metric | RNA | CMTV |
|---|---|---|
| Price | $12.82 | $40.99 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $69.26 | N/A |
| AVG Volume (30 Days) | ★ 340.0K | 18.2K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $88.12 | N/A |
| Revenue Next Year | $18.11 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.95 | $29.53 |
| 52 Week High | $73.06 | $42.80 |
| Indicator | RNA | CMTV |
|---|---|---|
| Relative Strength Index (RSI) | 28.53 | 61.69 |
| Support Level | $11.95 | $29.82 |
| Resistance Level | $14.80 | $42.80 |
| Average True Range (ATR) | 0.65 | 1.82 |
| MACD | 0.73 | 0.42 |
| Stochastic Oscillator | 15.09 | 85.99 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Community Bancorp Inc is a holding company that provides a complete line of personal and business banking services with personal services and solutions. The company mainly offers Business banking, Commercial real estate lending, residential real estate lending, Retail credit, Municipal and Institutional Banking, and Retail Banking. The company's primary lending products are commercial, real estate, municipal, and consumer loans. The bank offers a complete line of personal and business products and services, along with offerings for non-profit organizations, municipalities, and local governments. The Firm also engages in lending activity outside the area of its branch network, through loan production offices in Burlington, Vermont, and Lebanon, New Hampshire.